respiratory

News in brief: ATAGI prioritises children with lung disease for Pfizer vax; Home testing for OSA in kids is feasible; Health impact of bushfire smoke revealed

ATAGI recommends Pfizer vaccine for children with chronic lung conditions Children aged 12–15 with lung disease such as cystic fibrosis and severe asthma  are among the high risk groups for COVID-19 that should prioritised for vaccination using the Comirnaty (Pfizer) vaccine, according to the Australian Technical Advisory Group on Immunisation (ATAGI) Following the recent TGA ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic